Xiangyou Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiangyou Yu has a total of 148 co-authors. Here are the top co-authors by number of shared publications:
Yi Wang
Centre for Critical Care Medicine, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, 830054, China
13 shared publicationsWenzhe Li
Department of Critical Care Medicine, The First Affiliated Hospital of Xinjiang Medical University
10 shared publicationsChunbo Yang
Department of Critical Medicine, the First Affiliated Hospital of Xinjiang Medical University
7 shared publicationsPengfei Pan
Department of Critical Care Medicine, Chongqing University Three Gorges Hospital, Chongqing, China
7 shared publicationsXinxin Du
Cardiac Intensive Care Center, Zhongshan Hospital, Fudan University, Shanghai, China
7 shared publicationsLi Zhang
Department of Nursing, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, 830054, China
6 shared publications
Latest Publications
- Open Access
- 4 June 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1030, 179038
Survival benefit analysis of beta-blockers in patients with sepsis-induced TnT-positive myocardial injury across different clinical subtypes of sepsis: A retrospective study based on the MIMIC-IV database
- 4 June 2026
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1030, 179038
Open AccessSurvival benefit analysis of beta-blockers in patients with sepsis-induced TnT-positive myocardial injury across different clinical subtypes of sepsis: A retrospective study based on the MIMIC-IV database
- 1 May 2026
- Vol. 38 (5) , 431-437
[Mechanism of irisin in alleviating sepsis-associated acute kidney injury by inhibiting ferroptosis via the Nrf2/HO-1 signaling pathway].
To investigate the ameliorative effect of irisin on sepsis-associated acute kidney injury (SA-AKI) by inhibiting ferroptosis through the regulation of the nuclear factor E2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling pathway. Sixty C57BL/6 mice were divided into four groups using a random number table method: control group, lipopolysaccharide (LPS) group, LPS+irisin group, and LPS+irisin+ML385 (Nrf2 inhibitor) group, with 15 mice in each group. The SA-AKI model was established by intraperitoneal injection of LPS at a dose of 10 mg/kg, while the control group received an equal volume of normal saline. In the LPS+irisin group, irisin (1 μg/kg) was intravenously injected 30 minutes prior to LPS administration. In the LPS+irisin+ML385 group, ML385 (30 mg/kg) was intraperitoneally injected 60 minutes before LPS injection, followed by irisin injection 30 minutes before LPS. All mice were anesthetized and sacrificed 24 hours after modeling. Blood samples were collected from the eyeballs for serum creatinine (SCr) and blood urea nitrogen (BUN) measurement using an automatic biochemical analyzer. Renal tissues were harvested for the following assessments: the levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were measured by enzyme linked immunosorbent assay (ELISA); histopathological changes were observed under light microscope after hematoxylin-eosin (HE) staining; mitochondrial morphology was observed under transmission electron microscope after uranium acetate staining; protein expressions of glutathione peroxidase 4 (GPX4), acyl-CoA synthetase long-chain family member 4 (ACSL4), Nrf2, and HO-1 were detected by Western blotting; the contents of Fe2+, malondialdehyde (MDA), reduced glutathione (GSH), and relative fluorescence intensity of reactive oxygen species (ROS) were also measured in renal tissues. 1) The levels of SCr, BUN, IL-6, and TNF-α in the LPS, LPS+irisin, and LPS+irisin+ML385 groups were higher than those in the control group (all P2+; were increased, while the level of GSH was decreased in the LPS, LPS+irisin, and LPS+irisin+ML385 groups (all P2+, and increased level of GSH [MDA (nmol/mg): 9.35±2.07 vs. 15.65±4.03, ROS (relative fluorescence intensity): 584.26±74.48 vs. 1 655.68±405.71, Fe2+ (nmol/mg): 9.24±3.82 vs. 26.99±7.95, GSH (nmol/mg): 91.50±7.99 vs. 43.13±11.85, all P2+, and decreased level of GSH (all P<0.05). Irisin ameliorates LPS-induced SA-AKI in mice by inhibiting ferroptosis through the Nrf2/HO-1 signaling pathway, suggesting that irisin may serve as a potential therapeutic strategy for organ protection in sepsis.
- 1 May 2026
- Vol. 38 (5) , 431-437
[Mechanism of irisin in alleviating sepsis-associated acute kidney injury by inhibiting ferroptosis via the Nrf2/HO-1 signaling pathway].
To investigate the ameliorative effect of irisin on sepsis-associated acute kidney injury (SA-AKI) by inhibiting ferroptosis through the regulation of the nuclear factor E2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) signaling pathway. Sixty C57BL/6 mice were divided into four groups using a random number table method: control group, lipopolysaccharide (LPS) group, LPS+irisin group, and LPS+irisin+ML385 (Nrf2 inhibitor) group, with 15 mice in each group. The SA-AKI model was established by intraperitoneal injection of LPS at a dose of 10 mg/kg, while the control group received an equal volume of normal saline. In the LPS+irisin group, irisin (1 μg/kg) was intravenously injected 30 minutes prior to LPS administration. In the LPS+irisin+ML385 group, ML385 (30 mg/kg) was intraperitoneally injected 60 minutes before LPS injection, followed by irisin injection 30 minutes before LPS. All mice were anesthetized and sacrificed 24 hours after modeling. Blood samples were collected from the eyeballs for serum creatinine (SCr) and blood urea nitrogen (BUN) measurement using an automatic biochemical analyzer. Renal tissues were harvested for the following assessments: the levels of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were measured by enzyme linked immunosorbent assay (ELISA); histopathological changes were observed under light microscope after hematoxylin-eosin (HE) staining; mitochondrial morphology was observed under transmission electron microscope after uranium acetate staining; protein expressions of glutathione peroxidase 4 (GPX4), acyl-CoA synthetase long-chain family member 4 (ACSL4), Nrf2, and HO-1 were detected by Western blotting; the contents of Fe2+, malondialdehyde (MDA), reduced glutathione (GSH), and relative fluorescence intensity of reactive oxygen species (ROS) were also measured in renal tissues. 1) The levels of SCr, BUN, IL-6, and TNF-α in the LPS, LPS+irisin, and LPS+irisin+ML385 groups were higher than those in the control group (all P2+; were increased, while the level of GSH was decreased in the LPS, LPS+irisin, and LPS+irisin+ML385 groups (all P2+, and increased level of GSH [MDA (nmol/mg): 9.35±2.07 vs. 15.65±4.03, ROS (relative fluorescence intensity): 584.26±74.48 vs. 1 655.68±405.71, Fe2+ (nmol/mg): 9.24±3.82 vs. 26.99±7.95, GSH (nmol/mg): 91.50±7.99 vs. 43.13±11.85, all P2+, and decreased level of GSH (all P<0.05). Irisin ameliorates LPS-induced SA-AKI in mice by inhibiting ferroptosis through the Nrf2/HO-1 signaling pathway, suggesting that irisin may serve as a potential therapeutic strategy for organ protection in sepsis.
- Open Access
- 1 April 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-18
Genetic and Experimental Evidence Implicates CCL4 in Severe Sepsis Risk and Phase-Dependent Immune Dynamics
Background: Although inflammatory cytokines are pivotal to the pathogenesis of sepsis, determining their causal roles remains challenging due to confounding biases. We employed Mendelian randomization (MR) to investigate genetically determined cytokine levels in sepsis risk, with translational validation in clinical cohorts and experimental models. Methods: A multi-omics framework integrated cis-protein quantitative trait loci (cis-pQTL) of plasma cytokines with the UK Biobank sepsis GWAS using inverse-variance weighted MR and Wald ratio methods. Sensitivity analyses, Bayesian co-localization analysis, phenotype scanning, and bidirectional MR ensured robustness. Clinical validation compared peripheral levels of the result found by MR analysis in severe sepsis patients (n = 15) and non-septic ICU controls (n = 11) within 24 hours of diagnosis. The temporal dynamics were further characterized in the cecal ligation and puncture (CLP) rat model, assessing blood and lung protein and mRNA levels of the result found in MR analysis at 24 hours to 120 hours, along with T-cell exhaustion markers. Results: Genetically elevated levels of CCL4 (Chemokine CC motif ligand 4) were associated with critical sepsis risk (OR = 0.70, 95% CI: 0.58– 0.84, P = 1.45× 10− 4, FDR = 0.017), consistent across sensitivity analyses. Clinically, septic patients exhibited higher peripheral blood levels of CCL4 within 24 hours than controls. In the CLP rat model, peripheral and pulmonary CCL4 protein levels peaked at 24 hours but declined significantly by 120 hours. This decline was accompanied by transcriptomic evidence of T-cell exhaustion, with increased CTLA-4 and decreased IL-2 and IFN-γ. Conclusion: The trajectory of CCL4 follows distinct phases in sepsis—its early elevation is associated with hyperinflammation, while its later decline correlates with T-cell exhaustion. Although causal mechanisms require further validation, our findings propose that monitoring CCL4 dynamics may serve as a potential biomarker for immunophenotype stratification, highlighting its relevance for developing time-sensitive therapeutic strategies.
- 1 April 2026
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 19, 1-18
Open AccessGenetic and Experimental Evidence Implicates CCL4 in Severe Sepsis Risk and Phase-Dependent Immune Dynamics
Background: Although inflammatory cytokines are pivotal to the pathogenesis of sepsis, determining their causal roles remains challenging due to confounding biases. We employed Mendelian randomization (MR) to investigate genetically determined cytokine levels in sepsis risk, with translational validation in clinical cohorts and experimental models. Methods: A multi-omics framework integrated cis-protein quantitative trait loci (cis-pQTL) of plasma cytokines with the UK Biobank sepsis GWAS using inverse-variance weighted MR and Wald ratio methods. Sensitivity analyses, Bayesian co-localization analysis, phenotype scanning, and bidirectional MR ensured robustness. Clinical validation compared peripheral levels of the result found by MR analysis in severe sepsis patients (n = 15) and non-septic ICU controls (n = 11) within 24 hours of diagnosis. The temporal dynamics were further characterized in the cecal ligation and puncture (CLP) rat model, assessing blood and lung protein and mRNA levels of the result found in MR analysis at 24 hours to 120 hours, along with T-cell exhaustion markers. Results: Genetically elevated levels of CCL4 (Chemokine CC motif ligand 4) were associated with critical sepsis risk (OR = 0.70, 95% CI: 0.58– 0.84, P = 1.45× 10− 4, FDR = 0.017), consistent across sensitivity analyses. Clinically, septic patients exhibited higher peripheral blood levels of CCL4 within 24 hours than controls. In the CLP rat model, peripheral and pulmonary CCL4 protein levels peaked at 24 hours but declined significantly by 120 hours. This decline was accompanied by transcriptomic evidence of T-cell exhaustion, with increased CTLA-4 and decreased IL-2 and IFN-γ. Conclusion: The trajectory of CCL4 follows distinct phases in sepsis—its early elevation is associated with hyperinflammation, while its later decline correlates with T-cell exhaustion. Although causal mechanisms require further validation, our findings propose that monitoring CCL4 dynamics may serve as a potential biomarker for immunophenotype stratification, highlighting its relevance for developing time-sensitive therapeutic strategies.
- Open Access
- 16 March 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1789747
Elevated growth differentiation factor-15 in sepsis: clinical associations and immune cell context
Background: Early clinical assessment in sepsis remains challenging because of marked heterogeneity in host responses and the limited biological resolution of existing severity scores and conventional inflammatory biomarkers in capturing integrated cellular stress responses. Growth differentiation factor-15 (GDF-15) is a stress-responsive cytokine that is elevated in critical illness; however, its clinical associations and immune cell-specific context in sepsis remain incompletely characterized. Methods: In this prospective observational exploratory study, serum GDF-15 concentrations were measured by enzyme-linked immunosorbent assay in a small cohort of adult patients with sepsis (n = 19) and healthy controls (n = 23). Associations between circulating GDF-15 levels, disease severity scores, markers of organ dysfunction, and inflammatory biomarkers were assessed using non-parametric correlation analyses. To provide biological context, publicly available single-cell RNA sequencing data (GSE217906) were analyzed to characterize immune cell-specific patterns of GDF15 expression during acute sepsis. Results: Circulating GDF-15 concentrations were markedly elevated in patients with sepsis compared with healthy controls (median 1390 vs. 1050 pg/mL). Among patients with sepsis, higher GDF-15 levels were consistently observed in those with greater disease severity, and increased levels of inflammatory biomarkers. Analysis of independent single-cell transcriptomic data demonstrated increased GDF15 expression in immune cells during acute sepsis, with relative enrichment observed primarily in plasma cells and monocytes. Exploratory receiver operating characteristic analyses suggested that circulating GDF-15 exhibited descriptive discrimination patterns for 28-day mortality that were directionally similar to those of established severity scores and conventional inflammatory biomarkers. Conclusion: Circulating GDF-15 levels are elevated in sepsis and are associated with disease severity, organ dysfunction, and inflammatory activity. Immune cell-specific enrichment of GDF15 expression provides biological context for its elevation during acute sepsis. Together, these findings suggest that GDF-15 may reflect, at least in part, systemic biological stress in critical illness, warranting further investigation in larger, well-characterized cohorts.
- 16 March 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1789747
Open AccessElevated growth differentiation factor-15 in sepsis: clinical associations and immune cell context
Background: Early clinical assessment in sepsis remains challenging because of marked heterogeneity in host responses and the limited biological resolution of existing severity scores and conventional inflammatory biomarkers in capturing integrated cellular stress responses. Growth differentiation factor-15 (GDF-15) is a stress-responsive cytokine that is elevated in critical illness; however, its clinical associations and immune cell-specific context in sepsis remain incompletely characterized. Methods: In this prospective observational exploratory study, serum GDF-15 concentrations were measured by enzyme-linked immunosorbent assay in a small cohort of adult patients with sepsis (n = 19) and healthy controls (n = 23). Associations between circulating GDF-15 levels, disease severity scores, markers of organ dysfunction, and inflammatory biomarkers were assessed using non-parametric correlation analyses. To provide biological context, publicly available single-cell RNA sequencing data (GSE217906) were analyzed to characterize immune cell-specific patterns of GDF15 expression during acute sepsis. Results: Circulating GDF-15 concentrations were markedly elevated in patients with sepsis compared with healthy controls (median 1390 vs. 1050 pg/mL). Among patients with sepsis, higher GDF-15 levels were consistently observed in those with greater disease severity, and increased levels of inflammatory biomarkers. Analysis of independent single-cell transcriptomic data demonstrated increased GDF15 expression in immune cells during acute sepsis, with relative enrichment observed primarily in plasma cells and monocytes. Exploratory receiver operating characteristic analyses suggested that circulating GDF-15 exhibited descriptive discrimination patterns for 28-day mortality that were directionally similar to those of established severity scores and conventional inflammatory biomarkers. Conclusion: Circulating GDF-15 levels are elevated in sepsis and are associated with disease severity, organ dysfunction, and inflammatory activity. Immune cell-specific enrichment of GDF15 expression provides biological context for its elevation during acute sepsis. Together, these findings suggest that GDF-15 may reflect, at least in part, systemic biological stress in critical illness, warranting further investigation in larger, well-characterized cohorts.
- Open Access
- 12 March 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1775636
Development and validation of a prognostic model for acute respiratory distress syndrome in critically Ill patients with intra-abdominal sepsis: a multicenter cohort study
Background: To develop and externally validate a machine learning-based model for predicting the risk of acute respiratory distress syndrome (ARDS) in patients with intra-abdominal sepsis. Methods: Data were obtained from the MIMIC-IV and the eICU-CRD database, including patients diagnosed with intra-abdominal sepsis. ARDS occurrence during intensive care unit (ICU) stay was defined as the primary outcome. Feature selection was performed using a combination of the Boruta algorithm, LASSO regression, and logistic regression. Ten base machine learning algorithms were trained and integrated into a stacked ensemble model. Model performance was systematically evaluated, and interpretability was assessed using SHapley Additive exPlanations (SHAP). External validation was conducted in an independent cohort of patients with intra-abdominal sepsis admitted to the First Affiliated Hospital of Xinjiang Medical University between 2016 and 2024. A web-based risk prediction calculator was subsequently developed to facilitate clinical decision support. Results: Among 1,120 patients included from the MIMIC-IV and eICU-CRD databases, 554 (49.46%) developed ARDS during their ICU stay. Fourteen predictors were retained, including mechanical ventilation, use of vasoactive agents, history of chronic pulmonary disease, Sequential Organ Failure Assessment (SOFA) score, Glasgow Coma Scale (GCS) score, key vital signs, and routine laboratory indicators. The stacking model achieved areas under the receiver operating characteristic curve (AUC) of 0.811 in the development cohort, 0.794 in the internal validation cohort, and 0.756 in the external validation cohort. SHAP analysis identified mechanical ventilation as the most influential predictor, while early vasoactive agents use was associated with a reduced ARDS risk. Conclusion: A stacked ensemble model for predicting ARDS risk in patients with intra-abdominal sepsis demonstrated robust performance, stability, and interpretability. This model provides a practical tool for early risk stratification and informed clinical decision-making.
- 12 March 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1775636
Open AccessDevelopment and validation of a prognostic model for acute respiratory distress syndrome in critically Ill patients with intra-abdominal sepsis: a multicenter cohort study
Background: To develop and externally validate a machine learning-based model for predicting the risk of acute respiratory distress syndrome (ARDS) in patients with intra-abdominal sepsis. Methods: Data were obtained from the MIMIC-IV and the eICU-CRD database, including patients diagnosed with intra-abdominal sepsis. ARDS occurrence during intensive care unit (ICU) stay was defined as the primary outcome. Feature selection was performed using a combination of the Boruta algorithm, LASSO regression, and logistic regression. Ten base machine learning algorithms were trained and integrated into a stacked ensemble model. Model performance was systematically evaluated, and interpretability was assessed using SHapley Additive exPlanations (SHAP). External validation was conducted in an independent cohort of patients with intra-abdominal sepsis admitted to the First Affiliated Hospital of Xinjiang Medical University between 2016 and 2024. A web-based risk prediction calculator was subsequently developed to facilitate clinical decision support. Results: Among 1,120 patients included from the MIMIC-IV and eICU-CRD databases, 554 (49.46%) developed ARDS during their ICU stay. Fourteen predictors were retained, including mechanical ventilation, use of vasoactive agents, history of chronic pulmonary disease, Sequential Organ Failure Assessment (SOFA) score, Glasgow Coma Scale (GCS) score, key vital signs, and routine laboratory indicators. The stacking model achieved areas under the receiver operating characteristic curve (AUC) of 0.811 in the development cohort, 0.794 in the internal validation cohort, and 0.756 in the external validation cohort. SHAP analysis identified mechanical ventilation as the most influential predictor, while early vasoactive agents use was associated with a reduced ARDS risk. Conclusion: A stacked ensemble model for predicting ARDS risk in patients with intra-abdominal sepsis demonstrated robust performance, stability, and interpretability. This model provides a practical tool for early risk stratification and informed clinical decision-making.
- 1 July 2025
- Vol. 37 (7) , 664-670
[Epidemiology and prognostic risk factors of sepsis in Xinjiang Uygur Autonomous Region: a multicenter prospective cross-sectional survey].
To investigate the incidence of sepsis in Xinjiang Uygur Autonomous Region and the compliance with sepsis diagnosis and treatment guidelines in intensive care unit (ICU) at different levels of hospitals, and to identify the risk factors associated with poor prognosis in patients with sepsis in this region. A prospective cross-sectional survey was conducted in ICU of Xinjiang Uygur Autonomous Region Critical Care Medicine Alliance. The survey period was from 10:00 on January 31, 2024, to 09:59 on February 1, 2024. The patients diagnosed with sepsis admitted to the ICU during the study period were included in the analysis. Data on patient demographics, physiology, microbiology, and treatment protocols were collected, with follow-up until the 28th day after ICU admission or death. Baseline characteristics and treatment information of septic patients across different hospital levels were compared, as well as clinical data of septic patients with different 28-day outcomes. Multivariate Cox proportional hazards model was used to identify risk factors for 28-day death in septic patients. A total of 77 units of Xinjiang Uygur Autonomous Region Critical Care Medicine Alliance from 14 prefectures/cities in Xinjiang participated in the survey. On the survey day, 727 patients were admitted to ICU, of whom 179 (24.6%) were diagnosed with sepsis, and 64 (35.8%) died within 28 days, 115 (64.2%) survived. Among the participating institutions, 33 were tertiary hospitals (42.9%), managing 97 septic cases (54.2%), and 44 were secondary hospitals (57.1%), managing 82 septic cases (45.8%). The lactic acid monitoring rate and continuous renal replacement therapy (CRRT) rate for septic patients in tertiary hospitals were significantly higher than those in secondary hospitals [lactic acid monitoring rate: 92.8% (90/97) vs. 82.9% (68/82), CRRT rate: 17.5% (17/97) vs. 3.7% (3/82), both P < 0.05]. No statistically significant differences were observed between tertiary and secondary hospitals in length of ICU stay or 28-day mortality [length of ICU stay (days): 11.0 (16.0) vs. 10.0 (22.0), 28-day mortality: 35.1% (34/97) vs. 36.6% (30/82), both P > 0.05]. Compared with survivors, non-survivors had higher acute physiology and chronic health evaluation II (APACHE II) score, sequential organ failure assessment (SOFA) score, Charlson comorbidity index (CCI) score and lower Glasgow coma scale (GCS) score. Significant differences were noted in vital signs [heart rate, blood pressure, body temperature, pulse oxygen saturation (SpO2)], laboratory markers [red blood cell count (RBC), white blood cell count (WBC), lymphocyte ratio (LYM%), blood urea nitrogen (BUN), total protein (TP), albumin (Alb), pH value, base excess (BE)], and monitoring, diagnosis and treatment information (invasive blood pressure monitoring, mechanical ventilation, CRRT, usage of norepinephrine). Multivariate Cox proportional hazards model indicated that body temperature [hazard ratio (HR) = 1.416, 95% confidence interval (95%CI) was 1.022-1.961, P = 0.037] and WBC (HR = 1.040, 95%CI was 1.010-1.071, P = 0.009) were independent risk factors for 28-day death in patients with sepsis. Sepsis in Xinjiang Uygur Autonomous Region is characterized by a high mortality. In this region, tertiary hospitals demonstrate better compliance with bundled treatment strategies such as lactic acid monitoring and the usage of CRRT compared to secondary hospitals, yet they do not show significant advantages in clinical outcomes. Body temperature and WBC are independent risk factors for 28-day death in patients with sepsis in this region. However, clinicians should still consider the actual situation of patients, along with more optimal early warning indicators and comprehensive system assessments, to identify and prevent risk factors for adverse outcomes in patients.
- 1 July 2025
- Vol. 37 (7) , 664-670
[Epidemiology and prognostic risk factors of sepsis in Xinjiang Uygur Autonomous Region: a multicenter prospective cross-sectional survey].
To investigate the incidence of sepsis in Xinjiang Uygur Autonomous Region and the compliance with sepsis diagnosis and treatment guidelines in intensive care unit (ICU) at different levels of hospitals, and to identify the risk factors associated with poor prognosis in patients with sepsis in this region. A prospective cross-sectional survey was conducted in ICU of Xinjiang Uygur Autonomous Region Critical Care Medicine Alliance. The survey period was from 10:00 on January 31, 2024, to 09:59 on February 1, 2024. The patients diagnosed with sepsis admitted to the ICU during the study period were included in the analysis. Data on patient demographics, physiology, microbiology, and treatment protocols were collected, with follow-up until the 28th day after ICU admission or death. Baseline characteristics and treatment information of septic patients across different hospital levels were compared, as well as clinical data of septic patients with different 28-day outcomes. Multivariate Cox proportional hazards model was used to identify risk factors for 28-day death in septic patients. A total of 77 units of Xinjiang Uygur Autonomous Region Critical Care Medicine Alliance from 14 prefectures/cities in Xinjiang participated in the survey. On the survey day, 727 patients were admitted to ICU, of whom 179 (24.6%) were diagnosed with sepsis, and 64 (35.8%) died within 28 days, 115 (64.2%) survived. Among the participating institutions, 33 were tertiary hospitals (42.9%), managing 97 septic cases (54.2%), and 44 were secondary hospitals (57.1%), managing 82 septic cases (45.8%). The lactic acid monitoring rate and continuous renal replacement therapy (CRRT) rate for septic patients in tertiary hospitals were significantly higher than those in secondary hospitals [lactic acid monitoring rate: 92.8% (90/97) vs. 82.9% (68/82), CRRT rate: 17.5% (17/97) vs. 3.7% (3/82), both P < 0.05]. No statistically significant differences were observed between tertiary and secondary hospitals in length of ICU stay or 28-day mortality [length of ICU stay (days): 11.0 (16.0) vs. 10.0 (22.0), 28-day mortality: 35.1% (34/97) vs. 36.6% (30/82), both P > 0.05]. Compared with survivors, non-survivors had higher acute physiology and chronic health evaluation II (APACHE II) score, sequential organ failure assessment (SOFA) score, Charlson comorbidity index (CCI) score and lower Glasgow coma scale (GCS) score. Significant differences were noted in vital signs [heart rate, blood pressure, body temperature, pulse oxygen saturation (SpO2)], laboratory markers [red blood cell count (RBC), white blood cell count (WBC), lymphocyte ratio (LYM%), blood urea nitrogen (BUN), total protein (TP), albumin (Alb), pH value, base excess (BE)], and monitoring, diagnosis and treatment information (invasive blood pressure monitoring, mechanical ventilation, CRRT, usage of norepinephrine). Multivariate Cox proportional hazards model indicated that body temperature [hazard ratio (HR) = 1.416, 95% confidence interval (95%CI) was 1.022-1.961, P = 0.037] and WBC (HR = 1.040, 95%CI was 1.010-1.071, P = 0.009) were independent risk factors for 28-day death in patients with sepsis. Sepsis in Xinjiang Uygur Autonomous Region is characterized by a high mortality. In this region, tertiary hospitals demonstrate better compliance with bundled treatment strategies such as lactic acid monitoring and the usage of CRRT compared to secondary hospitals, yet they do not show significant advantages in clinical outcomes. Body temperature and WBC are independent risk factors for 28-day death in patients with sepsis in this region. However, clinicians should still consider the actual situation of patients, along with more optimal early warning indicators and comprehensive system assessments, to identify and prevent risk factors for adverse outcomes in patients.
- Open Access
Structural and temporal dynamics analysis on PANoptosis in sepsis: a bibliometric analysis
PANoptosis, as a new type of programmed cell death, is characterized by pyroptosis, apoptosis and necroptosis, and is a key mechanism causing a variety of inflammatory diseases. Despite the growing number of studies indicating the crucial role of PANoptosis in sepsis, there has been no bibliometric analysis of the research hotspots and trends in this field. Therefore, this study aims to explore the history, research hotspots and emerging trends of PANoptosis in sepsis related research in the past 20 years from the perspective of structure and temporal dynamics. The articles related to PANoptosis in sepsis were retrieved from the Web of Science Core Collection (WoSCC) database from 2000 to 2024. CiteSpace and HistCite were used to analyse the historical features, the evolution of active topics, and emerging trends about PANoptosis in sepsis. 6165 original articles and reviews on PANoptosis in sepsis were included in the bibliometric analysis. In the last 20 years, the number of published documents is increasing year by year and reaches a peak in 2022. At the same time, many activation themes have emerged at different times, as evidenced by a total of 96 categories, 865 keywords and 629 reference bursts. Keyword clustering anchored eight emerging research subfields, namely 0# oxidative stress, 1#pyroptosis, 2#sepsis-associated encephalopathy, 3#acute kidney injury, 4#immunosuppression, 5#necroptosis, 7#lung injury and 8#extracellular vesicles. The keyword alluvial map shows that the most persistent research concepts in this field are phosphatase. And the emerging keywords are toll_like_receptors, regulatory T cells, recognition, etc. In a timeline visualization based on the time span of the citations, we find five relevant emerging topics, namely 1# immunosuppression, 2# sepsis-induced cardiomyopathy, 3# pyroptosis, 4# acute kidney injury, and 13# COVID-19. Our study provides a comprehensive bibliometric analysis and summary about the current status and trends on PANoptosis in sepsis, which will aid researchers in conducting further scientific research in this field.
Open AccessStructural and temporal dynamics analysis on PANoptosis in sepsis: a bibliometric analysis
PANoptosis, as a new type of programmed cell death, is characterized by pyroptosis, apoptosis and necroptosis, and is a key mechanism causing a variety of inflammatory diseases. Despite the growing number of studies indicating the crucial role of PANoptosis in sepsis, there has been no bibliometric analysis of the research hotspots and trends in this field. Therefore, this study aims to explore the history, research hotspots and emerging trends of PANoptosis in sepsis related research in the past 20 years from the perspective of structure and temporal dynamics. The articles related to PANoptosis in sepsis were retrieved from the Web of Science Core Collection (WoSCC) database from 2000 to 2024. CiteSpace and HistCite were used to analyse the historical features, the evolution of active topics, and emerging trends about PANoptosis in sepsis. 6165 original articles and reviews on PANoptosis in sepsis were included in the bibliometric analysis. In the last 20 years, the number of published documents is increasing year by year and reaches a peak in 2022. At the same time, many activation themes have emerged at different times, as evidenced by a total of 96 categories, 865 keywords and 629 reference bursts. Keyword clustering anchored eight emerging research subfields, namely 0# oxidative stress, 1#pyroptosis, 2#sepsis-associated encephalopathy, 3#acute kidney injury, 4#immunosuppression, 5#necroptosis, 7#lung injury and 8#extracellular vesicles. The keyword alluvial map shows that the most persistent research concepts in this field are phosphatase. And the emerging keywords are toll_like_receptors, regulatory T cells, recognition, etc. In a timeline visualization based on the time span of the citations, we find five relevant emerging topics, namely 1# immunosuppression, 2# sepsis-induced cardiomyopathy, 3# pyroptosis, 4# acute kidney injury, and 13# COVID-19. Our study provides a comprehensive bibliometric analysis and summary about the current status and trends on PANoptosis in sepsis, which will aid researchers in conducting further scientific research in this field.
- 1 April 2025
- Vol. 37 (4) , 331-336
[Predictive value of norepinephrine equivalence score on the 28-day death risk in patients with sepsis: a retrospective cohort study].
To elucidate the predictive value of norepinephrine equivalence (NEE) score on the 28-day death risk in patients with sepsis and provide evidence for its application in the diagnosis and treatment of sepsis and septic shock. A retrospective cohort study was conducted based on the data of patients with sepsis from Medical Information Mart for Intensive Care-IV 2.2 (MIMIC-IV 2.2). The patients who received vasoactive agents within 6 hours after the diagnosis of sepsis or septic shock were enrolled, and they were divided into survival and non-survival groups based on their 28-day outcomes. The baseline characteristics, vital signs, and treatment data were collected. Multivariate Cox regression analysis was performed to identify factors influencing the 28-day death risk. Receiver operator characteristic curve (ROC curve) was drawn to analyze the predictive value of various parameters on the 28-day death risk of septic patients. Kaplan-Meier survival curve was used to evaluate cumulative survival rate in patients classified by different quantitative parameters based on the cut-off values obtained from ROC curve analysis. A total of 7 744 patients who met the Sepsis-3 diagnostic criteria and received vasopressor treatment within 6 hours post-diagnosis were enrolled, of which 5 997 cases survived and 1 747 died, with the 28-day mortality of 22.6%. Significant differences were observed between the two groups regarding age, gender, height, body weight, race, type of intensive care unit (ICU), acute physiology and chronic health evaluation II (APACHE II) score, sequential organ failure assessment (SOFA) score, Charlson comorbidity index (CCI) score, underlying comorbidities, and vital signs. Compared with the survival group, the non-survival group had poorer blood routine, liver and kidney function, coagulation function, blood gas analysis and other indicators. Multivariate Cox regression analysis revealed that age > 65 years old [hazard ratio (HR) = 0.892, 95% confidence interval (95%CI) was 0.801-0.994, P = 0.039] and male (HR = 0.735, 95%CI was 0.669-0.808, P < 0.001) were protective factors for 28-day death in patients with sepsis, and NEE score (HR = 1.040, 95%CI was 1.021-1.060, P < 0.001), shock index (HR = 1.840, 95%CI was 1.675-2.022, P < 0.001), APACHE II score (HR = 1.076, 95%CI was 1.069-1.083, P < 0.001), SOFA score (HR = 1.035, 95%CI was 1.015-1.056, P < 0.001), and CCI score (HR = 1.135, 95%CI was 1.115-1.155, P < 0.001) were independent risk factors for 28-day death in septic patients. ROC curve analysis showed that the area under the ROC curve (AUC) of NEE score for predicting the 28-day death risk of septic patients was 0.743 (95%CI was 0.730-0.756), which was comparable to the predictive value of APACHE II score (AUC = 0.742, 95%CI was 0.729-0.755) and ratio of mean arterial pressure (MAP)/NEE score (MAP/NEE; AUC = 0.738, 95%CI was 0.725-0.751, both P > 0.05), and better than SOFA score (AUC = 0.609, 95%CI was 0.594-0.624), CCI score (AUC = 0.658, 95%CI was 0.644-0.673), shock index (AUC = 0.613, 95%CI was 0.597-0.629) and ratio of diastolic blood pressure (DBP)/NEE score (DBP/NEE; AUC = 0.735, 95%CI was 0.721-0.748, all P < 0.05). According to the cut-off values of APACHE II and NEE scores obtained from ROC curve analysis, the patients were stratified for Kaplan-Meier survival curve analysis, and the results showed that the 28-day cumulative survival rate in the septic patients with an APACHE II score ≤ 22.5 was significantly higher than that in those with an APACHE II > 22.5 (Log-Rank test: χ2 = 848.600, P < 0.001), and the 28-day cumulative survival rate in the septic patients with an NEE score ≤0.120 was significantly higher than that in those with an NEE score > 0.120 (Log-Rank test: χ2 = 832.449, P < 0.001). NEE score is an independent risk factor for 28-day death in septic patients who received vasoactive treatment within 6 hours of diagnosis and possesses significant predictive value. It can be used for severity stratification in sepsis management.
- 1 April 2025
- Vol. 37 (4) , 331-336
[Predictive value of norepinephrine equivalence score on the 28-day death risk in patients with sepsis: a retrospective cohort study].
To elucidate the predictive value of norepinephrine equivalence (NEE) score on the 28-day death risk in patients with sepsis and provide evidence for its application in the diagnosis and treatment of sepsis and septic shock. A retrospective cohort study was conducted based on the data of patients with sepsis from Medical Information Mart for Intensive Care-IV 2.2 (MIMIC-IV 2.2). The patients who received vasoactive agents within 6 hours after the diagnosis of sepsis or septic shock were enrolled, and they were divided into survival and non-survival groups based on their 28-day outcomes. The baseline characteristics, vital signs, and treatment data were collected. Multivariate Cox regression analysis was performed to identify factors influencing the 28-day death risk. Receiver operator characteristic curve (ROC curve) was drawn to analyze the predictive value of various parameters on the 28-day death risk of septic patients. Kaplan-Meier survival curve was used to evaluate cumulative survival rate in patients classified by different quantitative parameters based on the cut-off values obtained from ROC curve analysis. A total of 7 744 patients who met the Sepsis-3 diagnostic criteria and received vasopressor treatment within 6 hours post-diagnosis were enrolled, of which 5 997 cases survived and 1 747 died, with the 28-day mortality of 22.6%. Significant differences were observed between the two groups regarding age, gender, height, body weight, race, type of intensive care unit (ICU), acute physiology and chronic health evaluation II (APACHE II) score, sequential organ failure assessment (SOFA) score, Charlson comorbidity index (CCI) score, underlying comorbidities, and vital signs. Compared with the survival group, the non-survival group had poorer blood routine, liver and kidney function, coagulation function, blood gas analysis and other indicators. Multivariate Cox regression analysis revealed that age > 65 years old [hazard ratio (HR) = 0.892, 95% confidence interval (95%CI) was 0.801-0.994, P = 0.039] and male (HR = 0.735, 95%CI was 0.669-0.808, P < 0.001) were protective factors for 28-day death in patients with sepsis, and NEE score (HR = 1.040, 95%CI was 1.021-1.060, P < 0.001), shock index (HR = 1.840, 95%CI was 1.675-2.022, P < 0.001), APACHE II score (HR = 1.076, 95%CI was 1.069-1.083, P < 0.001), SOFA score (HR = 1.035, 95%CI was 1.015-1.056, P < 0.001), and CCI score (HR = 1.135, 95%CI was 1.115-1.155, P < 0.001) were independent risk factors for 28-day death in septic patients. ROC curve analysis showed that the area under the ROC curve (AUC) of NEE score for predicting the 28-day death risk of septic patients was 0.743 (95%CI was 0.730-0.756), which was comparable to the predictive value of APACHE II score (AUC = 0.742, 95%CI was 0.729-0.755) and ratio of mean arterial pressure (MAP)/NEE score (MAP/NEE; AUC = 0.738, 95%CI was 0.725-0.751, both P > 0.05), and better than SOFA score (AUC = 0.609, 95%CI was 0.594-0.624), CCI score (AUC = 0.658, 95%CI was 0.644-0.673), shock index (AUC = 0.613, 95%CI was 0.597-0.629) and ratio of diastolic blood pressure (DBP)/NEE score (DBP/NEE; AUC = 0.735, 95%CI was 0.721-0.748, all P < 0.05). According to the cut-off values of APACHE II and NEE scores obtained from ROC curve analysis, the patients were stratified for Kaplan-Meier survival curve analysis, and the results showed that the 28-day cumulative survival rate in the septic patients with an APACHE II score ≤ 22.5 was significantly higher than that in those with an APACHE II > 22.5 (Log-Rank test: χ2 = 848.600, P < 0.001), and the 28-day cumulative survival rate in the septic patients with an NEE score ≤0.120 was significantly higher than that in those with an NEE score > 0.120 (Log-Rank test: χ2 = 832.449, P < 0.001). NEE score is an independent risk factor for 28-day death in septic patients who received vasoactive treatment within 6 hours of diagnosis and possesses significant predictive value. It can be used for severity stratification in sepsis management.
- Open Access
- 20 January 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-8
Cardiac hydatid cyst: case series and review of the literature
Echinococcosis is a zoonotic parasitic disease prevalent in pastoral areas, mainly involving the liver and lungs, and rarely affecting the brain and heart. This article describes the diagnosis and treatment of 14 patients with cardiac encapsulated cysts, with the aim of providing insights into the clinical presentation, diagnostic challenges, therapeutic strategies, and outcomes associated with cardiac encapsulated cysts. This retrospective case series included 13 patients with cardiac and/or cerebral encapsulated cysts. We retrospectively analyzed 14 patients diagnosed with cardiac and pericardial echinococcosis between 2012 and 2024 at our hospital. The patients’ average age was 26 years, ranging from 3 to 60 years. Echinococcal cysts were found in various cardiac locations, including the pericardium (5 patients), left ventricle (3 patients), right atrium (2 patients), and apical region of the heart (1 patient). Chest pain (6 patients) was a common symptom if the cyst was in the heart, dyspnea, or cough (3 patients) if it was in the lungs, and epilepsy (1 patient) if it was in the brain. Diagnosis of this condition necessitates the performance of both laboratory tests and imaging procedures. The latter requires the expertise of a trained professional to accurately differentiate between cardiac-encapsulated cysts and other types of cysts. All patients in our study were examined as described above. The recommended course of treatment is typically surgical removal of the cyst and administration of medications to prevent recurrence. In instances where the patient declines to surgery, it is advised that they be provided with medication and scheduled for regular follow-up appointments. In our study, data were lost for two patients. Eight patients underwent open-heart surgery, one underwent craniotomy for epilepsy, one underwent thoracentesis and drainage for pleural effusion, and one patient declined surgery. Cardiac echinococcosis is common in pastoral populations, Surgical excision combined with pharmacological treatment is the best option for the treatment of cardiac echinococcosis.
- 20 January 2025
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 25 (1) , 1-8
Open AccessCardiac hydatid cyst: case series and review of the literature
Echinococcosis is a zoonotic parasitic disease prevalent in pastoral areas, mainly involving the liver and lungs, and rarely affecting the brain and heart. This article describes the diagnosis and treatment of 14 patients with cardiac encapsulated cysts, with the aim of providing insights into the clinical presentation, diagnostic challenges, therapeutic strategies, and outcomes associated with cardiac encapsulated cysts. This retrospective case series included 13 patients with cardiac and/or cerebral encapsulated cysts. We retrospectively analyzed 14 patients diagnosed with cardiac and pericardial echinococcosis between 2012 and 2024 at our hospital. The patients’ average age was 26 years, ranging from 3 to 60 years. Echinococcal cysts were found in various cardiac locations, including the pericardium (5 patients), left ventricle (3 patients), right atrium (2 patients), and apical region of the heart (1 patient). Chest pain (6 patients) was a common symptom if the cyst was in the heart, dyspnea, or cough (3 patients) if it was in the lungs, and epilepsy (1 patient) if it was in the brain. Diagnosis of this condition necessitates the performance of both laboratory tests and imaging procedures. The latter requires the expertise of a trained professional to accurately differentiate between cardiac-encapsulated cysts and other types of cysts. All patients in our study were examined as described above. The recommended course of treatment is typically surgical removal of the cyst and administration of medications to prevent recurrence. In instances where the patient declines to surgery, it is advised that they be provided with medication and scheduled for regular follow-up appointments. In our study, data were lost for two patients. Eight patients underwent open-heart surgery, one underwent craniotomy for epilepsy, one underwent thoracentesis and drainage for pleural effusion, and one patient declined surgery. Cardiac echinococcosis is common in pastoral populations, Surgical excision combined with pharmacological treatment is the best option for the treatment of cardiac echinococcosis.